Driven by growing demand for at-home health monitoring, domestic household medical devices are embracing new development opportunities, with independent R&D capacity emerging as enterprises’ core competitiveness. Rooted in Dandong, Hailais Biotechnology (Dandong) Co., Ltd. delves into independent development of blood glucose monitoring equipment. Committed to self-reliant technology and localized innovation, it continuously optimizes user experience of home monitoring devices.

The company collaborates actively with local universities and bio-industrial institutions for technical exchanges. Joint research focuses on eco-friendly materials, portable design and long-term stability of household IVD products. It absorbs cutting-edge industry technologies and achieves localized adaptation tailored to Chinese household scenarios.

Moreover, a long-term R&D investment mechanism is in place. A fixed share of annual revenue is allocated to lab equipment upgrades, talent recruitment and new product development. The enterprise expands its portfolio of supporting blood glucose monitoring supplies, forming an integrated lineup of meters, test strips and consumables to meet diverse procurement demands of households, retail outlets and primary medical institutions.

Hailais adheres to compliant innovation, with all technical improvements confined to the scope stated in registration specifications. Going forward, leveraging local geographical strengths, it will deepen its presence in household IVD sector. Bolstering the foundation of domestic medical device brands via independent R&D, it will supply more compliant, practical local products for China’s at-home health monitoring market.